Table 3 Clinical and histological data relating to the benign (Ben.) and malignant (Mal.) breast tissues. Data includes patient menopausal status and histological type, and tumour size, T, N, M, UICC stage, grade, ER, PR and HER2/neu status and intrinsic subtype of malignant tissues where available

Mal.

35

2

1

0

2B

3

pre

ductal

Mal.

22

2

1

0

2B

2

post

ductal

luminal A

8

4

negative

Mal.

22

2

0

0

2B

3

pre

ductal

basal

0

0

negative

Mal.

25

2

0

0

2A

pre

ductal

unknown

Mal.

37

2

1

0

2B

3

pre

ductal

luminal A

8

8

negative

Mal.

35

2

1

0

2B

1

pre

lobular

luminal A

7

8

negative

Mal.

45

2

1

0

2B

3

pre

ductal

basal

0

0

negative

Ben.

pre

fibrocystic

Mal.

20

1

1

0

2A

1

post

ductal

luminal A

8

8

negative

Mal.

50

2

1

0

2B

3

post

ductal

luminal B

8

3

positive

Mal.

15

1

1

0

2A

2

post

ductal

luminal A

8

3

negative

Mal.

20

1

0

0

1

2

post

ductal

luminal A

8

8

negative

Mal.

25

4

1

0

3B

3

post

ductal

luminal B

4

4

positive

Mal.

10

1

0

0

1

post

ductal, some tubular

luminal A

8

8

negative

Mal.

33

2

1

0

2B

1

post

lobular

luminal A

8

8

negative

Mal.

30

2

1

0

2B

3

pre

ductal

luminal A

7

8

negative

Mal.

30

2

1

0

2B

3

pre

ductal

0

0

Mal.

20

1

1

post

colloid/mucinous

Mal.

40

2

1

0

2B

2

post

lobular

luminal B

8

0

positive

Ben.

Ben.

pre

fibroadenoma

Ben.

pre

parenchymal inflammation

Mal.

35

4

2

0

3B

3

post

ductal

luminal A

8

8

negative

Mal.

35

2

1

0

2B

3

post

ductal

luminal A

8

6

negative

Mal.

pre

ductal

luminal A

7

0

negative

Mal.

25

2

0

0

2A

2

pre

ductal

Her2

0

0

positive

Mal.

60

4

2

1

4

2

Ben.

pre

Ben.

pre

fibroadenoma